Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mouse immunoglobulin G2a (IgG2a) is a subclass of murine immunoglobulin G (IgG) antibodies[1][2]. It is regarded as the "classical" or "canonical" IgG2 structure, characterized by four intact disulfide bonds in the hinge region[1]. IgG2a plays a key role in pathogen defense, primarily through opsonization (marking pathogens for phagocytosis), complement fixation (activating the complement cascade), and mediating immune effector functions[1]. It is one of the predominant isotypes produced in mice in response to infection with DNA or RNA viruses[6]. Structurally, IgG2a consists of two identical heavy chains (~50 kDa each) and two identical light chains (~25 kDa each), linked by disulfide bonds, forming a Y-shaped molecule with a total molecular weight of approximately 150,000 Da[1][5]. The Fc region of IgG2a can bind to the neonatal Fc receptor (FcRn), which helps prolong its half-life in circulation[2]. While IgG2a is not a therapeutic target itself, it is widely used as a research tool (e.g., isotype control, ELISA detection) and its levels are measured to study immune responses in various experimental models[3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mouse immunoglobulin G2a (IgG2a) (IgG2a).